Related Experiment Video
Updated: Aug 17, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Association between polycystic ovary syndrome and glucose intolerance during pregnancy
1Department of Obstetrics and Gynecology, University of Arizona Health Sciences Center, Tucson 85724, USA.
Abstract:
The purpose of our study was to determine if women with polycystic ovary syndrome are more likely than other women with infertility to develop gestational diabetes. All women who were successfully treated for infertility in the reproductive endocrinology clinic at the University of Arizona Health Sciences Center from January 1, 1990, to January 1, 1995, were identified. A retrospective cohort study was performed comparing the incidence of gestational diabetes and abnormal diabetic screening tests among subjects with polycystic ovary syndrome (N = 24) and a general infertility control group (N = 44). The incidence of gestational diabetes diagnosed in subjects with a history of polycystic ovary disease was similar to the incidence of gestational diabetes in subjects with infertility not ascribed to polycystic ovary disease (four subjects, 16.7% v. three subjects, 6.7%; relative risk [RR] 2.05, 95% confidence interval [CI] 0.31-13.57). A greater number of subjects with polycystic ovary syndrome had a positive diabetic screening test compared to the control group (13 subjects, 54% v. 10 subjects, 23%; RR 2.44, 95% CI 1.26-4.71). Our study suggests that women with polycystic ovary syndrome are more likely to have a positive diabetic screening test, but no more likely to have gestational diabetes than other women with infertility.
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction
Hyperglycemia

